Published in Am J Med on May 01, 1965
An antiviral substance from Penicillium funiculosum. V. Induction of interferon by helenine. J Exp Med (1966) 1.63
Interferon in the cerebrospinal fluid of children with central nervous system disorders. Can Med Assoc J (1967) 0.97
Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development. Cytokine Growth Factor Rev (2012) 0.94
Coxsackie group B fatal neonatal myocarditis associated with cardiomegaly. J Clin Pathol (1966) 0.85
Interferon: a changing picture. Can Med Assoc J (1966) 0.79
Interferon--1968. How much do we understand? Calif Med (1968) 0.77
The effects of therapeutic measures in diseases caused by viruses. Can Med Assoc J (1966) 0.75
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med (1954) 6.51
New antigenic variant in Far East influenza epidemic, 1957. Proc Soc Exp Biol Med (1957) 3.82
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med (1962) 3.32
TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7. Proc Soc Exp Biol Med (1964) 3.15
Characterization and classification of ECHO 28-rhinovirus-coryzavirus agents. Proc Soc Exp Biol Med (1962) 3.06
Antigenic pattern of strains of influenza A and B. Proc Soc Exp Biol Med (1950) 2.70
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med (1961) 2.66
Purification and characterization of chick embryo interferon. Proc Soc Exp Biol Med (1963) 2.57
The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1951) 2.39
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med (1961) 2.11
Distribution and significance of Asian and other influenza antibodies in the human population. N Engl J Med (1958) 1.97
Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA (1962) 1.92
System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc Soc Exp Biol Med (1951) 1.88
EFFECTIVE TREATMENT OF EXPERIMENTAL HERPES SIMPLEX KERATITIS WITH NEW DERIVATIVE, 5-METHYLAMINO-2'-DEOXYURIDINE (MADU). Proc Soc Exp Biol Med (1965) 1.84
Adenoviruses: group name proposed for new respiratory-tract viruses. Science (1956) 1.82
Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. J Immunol (1953) 1.81
Contributions to characterization and classification of animal viruses. Proc Soc Exp Biol Med (1963) 1.73
Laboratory studies on the 1950 outbreak of influenza. Public Health Rep (1950) 1.67
Recovery of new viruses (coryzavirus) from cases of common cold in human adults. Proc Soc Exp Biol Med (1961) 1.67
Use of living attenuated measles-virus vaccine in early infancy. N Engl J Med (1960) 1.62
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60
Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med (1955) 1.56
Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg (1955) 1.47
Antibody response in volunteers to Asian influenza vaccine. J Am Med Assoc (1958) 1.45
Search for virus in human malignancies. I. In vitro studies. Proc Soc Exp Biol Med (1962) 1.44
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med (1961) 1.43
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc Soc Exp Biol Med (1956) 1.43
ATTEMPTS TO INTERRUPT VIRUS TUMORIGENESIS BY IMMUNIZATION USING HOMOLOGOUS "BJORKLUND-TYPE" ANTIGEN. Proc Soc Exp Biol Med (1963) 1.41
Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health (1955) 1.34
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. J Immunol (1961) 1.33
INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN. Proc Soc Exp Biol Med (1964) 1.32
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med (1962) 1.31
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med (1964) 1.30
Influenza antibodies in the population of the USA; an epidemiological investigation. Bull World Health Organ (1953) 1.30
Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. Am J Dis Child (1962) 1.25
Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg (1957) 1.24
A safe high-speed blendor for processing infectious materials. J Lab Clin Med (1958) 1.21
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. J Immunol (1961) 1.20
Factors influencing tumor induction in hamsters by vacuolating virus, SV. Proc Soc Exp Biol Med (1963) 1.20
Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. Public Health Rep (1951) 1.20
Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med (1962) 1.20
EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med (1964) 1.19
ADDITIONAL RHINOVIRUS SEROTYPES. Proc Soc Exp Biol Med (1965) 1.19
Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci (1957) 1.18
Effect of Westphal lipid A on viral activities in mice and hamsters. Proc Soc Exp Biol Med (1962) 1.15
Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Organ (1957) 1.11
Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. J Immunol (1952) 1.10
A guinea pig potency test for adenovirus vaccine. J Immunol (1960) 1.10
A pattern of antigen variation. Fed Proc (1952) 1.10
Electron microscopy of type 4 adenovirus strain R1-67. Virology (1957) 1.06
Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. J Immunol (1958) 1.04
A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. Am Rev Respir Dis (1964) 1.03
Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). Am J Med (1956) 1.03
Immunologic studies of measles. Am J Hyg (1961) 1.00
In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1952) 0.98
Grouping and occurrence of RI (prototype RI-67) viruses. Proc Soc Exp Biol Med (1955) 0.97
Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy. Am J Public Health Nations Health (1962) 0.96
Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic. Am J Dis Child (1962) 0.96
Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions. Am J Dis Child (1962) 0.95
CHARACTERIZATION OF CHICK EMBRYO INTERFERON INDUCED BY A DNA VIRUS. Proc Soc Exp Biol Med (1965) 0.94
Administration of Enders' live measles virus vaccine with human immune globulin. JAMA (1962) 0.94
Development of a purified poliomyelitis virus vaccine. JAMA (1961) 0.92
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS. Proc Soc Exp Biol Med (1964) 0.91
Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J Lab Clin Med (1956) 0.91
RESPIRATORY SYNCYTIAL VIRUS. Am Rev Respir Dis (1963) 0.91
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN. N Engl J Med (1964) 0.91
Antigenic variation of influenza viruses. Annu Rev Microbiol (1954) 0.90
Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients. J Lab Clin Med (1958) 0.89
CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS. Am Rev Respir Dis (1963) 0.89
Efficacy of and indications for use of adenovirus vaccine. Am J Public Health Nations Health (1958) 0.88
Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. J Immunol (1958) 0.87
FURTHER TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES AND MYCOPLASMA, WITH CORRELATIVE REVIEW. Proc Soc Exp Biol Med (1965) 0.87
Respiratory viruses and respiratory virus vaccines. Am Rev Respir Dis (1963) 0.87
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. J Immunol (1961) 0.87
STUDIES OF ONCOGENICITY OF ADENOVIRUS TYPE 7 VIRUS IN HAMSTERS. Proc Soc Exp Biol Med (1965) 0.85
Acute respiratory illness in volunteers following intramuscular administration of live adenovirus. J Clin Invest (1957) 0.84
ECHO virus, type 25, in respiratory illness. Case report. J Pediatr (1963) 0.84
Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine. AMA Arch Intern Med (1958) 0.84
Occurrence and significance of adenovirus antibody in sera of recruit and cadre military personnel. Am J Hyg (1958) 0.83
Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development. J Am Med Assoc (1957) 0.82
Acute respiratory illness caused by adenoviruses; a military problem. U S Armed Forces Med J (1956) 0.82
An automatic pipette for preparing serial dilutions. J Lab Clin Med (1952) 0.81
INTERFERON IN PROSPECT AND PERSPECTIVE. J Cell Physiol (1963) 0.80
Studies of live attenuated measles virus vaccine in man. I. Clinical aspects. Am J Public Health Nations Health (1962) 0.78
THE ECHO 28-RHINOVIRUS-CORYZAVIRUS (ERC) GROUP OF VIRUSES. Am Rev Respir Dis (1963) 0.78
DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN. N Engl J Med (1964) 0.78
PROSPECTS FOR THE ROLE OF VIRUSES IN HUMAN MALIGNANCY. Health Lab Sci (1964) 0.77
Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology. Am J Public Health Nations Health (1957) 0.76
The parainfluenza viruses of man. Ann N Y Acad Sci (1962) 0.76
POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA. J Allergy (1964) 0.76
POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE. J Allergy (1964) 0.76
HOST-VIRUS RELATIONSHIPS IN HAMSTERS INOCULATED WITH SV40 VIRUS DURING THE NEONATAL PERIOD. Proc Soc Exp Biol Med (1964) 0.75
A simple tissue washer. Med Techn Bull (1951) 0.75
Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations. AMA Arch Intern Med (1958) 0.75
SEARCH FOR VIRUS IN HUMAN MALIGNANCIES. 3. SEX SEGREGATION AND NEOPLASIA IN ICR-HA MICE. Proc Soc Exp Biol Med (1963) 0.75
Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction. J Immunol (1946) 0.75
Mechanical apparatus for washing tissue cultures in tubes. J Immunol (1955) 0.75
The control of viral respiratory illnesses of man. J Hyg Epidemiol Microbiol Immunol (1962) 0.75
Search for virus in human malignancies. 2. In vivo studies. Proc Soc Exp Biol Med (1962) 0.75